# CISATRACURIUM BESYLATE
> **ANDA201851** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2020-11-06
## Drug
- **FDA Application Number:** ANDA201851
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** Cisatracurium Besylate
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS INC
- **First approval:** 2020-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201851)
---
*MORVS · CC0 1.0*